IP Library Granted Patent US 7,001,986
Granted Patent B2
US 7,001,986 · App. 09/887,784 · Granted Feb 21, 2006

Fluorescent proteins

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,001,986
App. No.
09/887,784
Granted
Feb 21, 2006
Kind
B2
Abstract

A GFP with an F64L mutation and an E222G mutation is provided. This GFP has a bigger Stokes shift compared to other GFPs making it very suitable for high throughput screening due to a better resolution. This GFP also has an excitation maximum between the yellow GFP and the cyan GFP allowing for cleaner band separation when used together with those GFPs.

Claims (13)

1. A fluorescent protein, as shown in SEQ ID NO: 4, wherein the amino acid in position 1 preceding the chromophore has been substituted by an aliphatic amino acid, and wherein the Glutamic acid in position 223 has been substituted by an amino acid selected from the group consisting of G, A, V. L and I.

2. A fluorescent protein according to claim 1 , wherein the chromophore is in position 66–68 of the predicted primary amino acid sequence of GEP as shown in SEQ ID NO: 4.

3. A fluorescent protein according to claim 1 or 2 , said protein being derived from Aequorea victoria or Renilla .

4. A fluorescent protein according to claim 1 , wherein the amino acid F in position 65 of the GFP has been substituted by an aliphatic amino acid.

5. A fluorescent protein according claim 1 , wherein the amino acid F in position 65 of the GFP has been substituted by an amino acid selected from the group consisting of L, I, V. A and G.

6. A fluorescent protein according to claim 1 , wherein the amino acid F in position 65 of the GFP has been substituted by L.

7. A fluorescent protein according to claim 1 , wherein the amino acid E in position 223 of the GFP has been substituted by G.

8. A fluorescent protein according to claim 1 having the amino acid sequence disclosed in SEQ ID NO: 4.

9. A fusion compound comprising a fluorescent protein (GFP) according to claim 1 , wherein the GFP is linked to a polypeptide.

10. A fusion compound according to claim 9 , wherein the polypeptide is a kinase or a cytoskeletal element.

11. A fusion compound according to claim 10 , wherein the polypeptide is the catalytic subunit of protein kinase A, protein kinase C, or Erkl.

12. A fluorescent protein according to claim 1 , wherein the amino acid E in position 223 of the GFP has been substituted by an amino acid selected from the group consisting of A, V, L and I.

13. A fluorescent protein, comprising a Green Fluorescent Protein (GFP) comprising an amino acid sequence wherein the amino acid at the position corresponding to position 65 of SEQ ID NO:4 is substituted with an aliphatic amino acid, and wherein the amino acid at the position corresponding to the position 223 of SEQ ID NO:4 has been substituted by an amino acid selected from the group consisting of G, A, V, L and I.

Assignments (3)
RE-RECORDING TO CORRECT ASSIGNEE ADDRESS REEL 17957 FRAME 0801 Recorded Aug 30, 2011
From: FISHER BIOIMAGE APS
To: FISHER BIOIMAGE APS
Reel/Frame 026836/0407 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2006
From: BIOIMAGE A/S
To: FISHER BIOIMAGE APS
Reel/Frame 017957/0801 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2001
From: BJORN, SARA PETERSEN; PAGLIARO, LEN; THASTRUP, OLE
To: BIOIMAGE A/S
Reel/Frame 012359/0881 →